Tag

CoherentMI, RNA Interference-based Therapy, Symptomatic Treatment, Acute Intermittent Porphyria, Acute Intermittent Porphyria Market, Acute Intermittent Porphyria Market Trend

#coherentmi-rna-interference-based-therapy-symptomatic-treatment-acute-intermittent-porphyria-acute-intermittent-porphyria-market-acute-intermittent-porphyria-market-trend

The Acute Intermittent Porphyria Market will grow at highest pace owing to rising prevalence of rare genetic diseases

Feb 26, 20253 min read

Acute Intermittent Porphyria (AIP) is a rare genetic disease characterized by attacks of severe abdominal pain, vomiting, and neurological...